According to AstraZeneca's latest financial reports the company's current earnings are S$54.07 Billion. , an increase over its 2023 earnings that were of S$11.42 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | S$13.97 B | 22.28% |
2023 | S$11.42 B | 122.77% |
2022 | S$5.13 B | 278.83% |
2021 | S$1.35 B | -80.51% |
2020 | S$6.94 B | 75.86% |
2019 | S$3.95 B | -12.18% |
2018 | S$4.49 B | -6.54% |
2017 | S$4.81 B | -26.94% |
2016 | S$6.58 B | 19.74% |
2015 | S$5.50 B | 86.05% |
2014 | S$2.95 B | -41.35% |
2013 | S$5.04 B | -54.57% |
2012 | S$11.10 B | -37.9% |
2011 | S$17.87 B | 11.18% |
2010 | S$16.08 B | 0% |
2009 | S$16.08 B | 31.29% |
2008 | S$12.24 B | 12.97% |
2007 | S$10.84 B | 0.97% |
2006 | S$10.73 B | 23.29% |
2005 | S$8.70 B | -2526.12% |
2004 | -S$0.36 Billion | -106.52% |
2003 | S$5.50 B | 3.54% |
2002 | S$5.31 B | -33.34% |
2001 | S$7.97 B | 49.57% |
2000 | S$5.33 B | |
1997 | S$3.02 B | -43.89% |
1996 | S$5.38 B | |
1994 | S$1.87 B | 22.61% |
1993 | S$1.52 B |